## Abstract ## Background Burkitt lymphoma (BL) accounts for 50% of childhood cancer in Malawi. Lack of resources precludes the use of new successful treatment approaches such as the LMB 89 group B protocol, which cures >80% of children with stage III BL with high dose chemotherapy and matching su
Burkitt lymphoma treatment: the Malawi experience
β Scribed by P.B. Hesseling
- Book ID
- 107665291
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- French
- Weight
- 162 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1965-0817
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Between 1991 and 1997, limited funding at times restricted available treatment for children with Burkitt lymphoma (BL) to cyclophosphamide (CPM) monotherapy at Lilongwe Central Hospital, Malawi. Our objective was to assess longβterm survival in Malawian children with Burk
## Abstract The cumulative results and longβterm followβup of all patients with Burkitt's lymphoma treated at the Uganda cancer Institute Kampala are reported. The annual admission rate is 29. The tumor patients commonly present with jaw swelling (72%), abdominal swelling (56%) and central nervous
The geographical and age distributions of endemic Burkitt's lymphoma (eBL), in Africa, parallel those of certain arboviruses, which include chikungunya fever. Increased incidences of antibodies to assorted arboviruses, including chikungunya, have been found in eBL sera compared to controls. An incre